66 results on '"Paul, Friedemann"'
Search Results
2. Normative Data and Conversion Equation for Spectral-Domain Optical Coherence Tomography in an International Healthy Control Cohort
3. Efficacy and Safety of Masitinib in Progressive Forms of Multiple Sclerosis: A Randomized, Phase 3, Clinical Trial
4. Choroid Plexus Volume in Multiple Sclerosis vs Neuromyelitis Optica Spectrum Disorder: A Retrospective, Cross-sectional Analysis
5. Leveraging Visual Outcome Measures to Advance Therapy Development in Neuroimmunologic Disorders
6. Interleukin-6 Receptor Blockade in Treatment-Refractory MOG-IgG–Associated Disease and Neuromyelitis Optica Spectrum Disorders
7. Retinal Optical Coherence Tomography in Neuromyelitis Optica
8. Wisdom of the expert crowd prediction of response for 3 neurology randomized trials
9. Increased Serum Neurofilament Light and Thin Ganglion Cell–Inner Plexiform Layer Are Additive Risk Factors for Disease Activity in Early Multiple Sclerosis
10. N2 year in review
11. Wisdom of the expert crowd prediction of response for 3 neurology randomized trials
12. Is APOE ε4 associated with cognitive performance in early MS?
13. Impact of treatment on cellular immunophenotype in MS: A cross-sectional study
14. Cortical topological network changes following optic neuritis
15. Does time equal vision in the acute treatment of a cohort of AQP4 and MOG optic neuritis?
16. Quantitative 7T MRI does not detect occult brain damage in neuromyelitis optica
17. Longitudinal optic neuritis-unrelated visual evoked potential changes in NMO spectrum disorders
18. N2 year in review
19. Apheresis therapies for NMOSD attacks: A retrospective study of 207 therapeutic interventions
20. Racial differences in neuromyelitis optica spectrum disorder
21. Venoplasty in MS: Therapeutic intervention without any evidence
22. VZV-associated acute retinal necrosis in a patient with MS treated with natalizumab
23. Temporal visual resolution and disease severity in MS
24. Intrathecal IgM production is a strong risk factor for early conversion to multiple sclerosis
25. Increased Retention of Gadolinium in the Inflamed Brain After Repeated Administration of Gadopentetate Dimeglumine: A Proof-of-Concept Study in Mice Combining ICP-MS and Micro– and Nano–SR-XRF
26. Safety and preliminary efficacy of deep transcranial magnetic stimulation in MS-related fatigue
27. N2 year in review and message from the editor to our reviewers
28. Gadolinium in human brain sections and colocalization with other elements
29. The International Multiple Sclerosis Visual System Consortium: Advancing Visual System Research in Multiple Sclerosis
30. Racial differences in neuromyelitis optica spectrum disorder
31. Venoplasty in MS: Therapeutic intervention without any evidence
32. Association of Visual Impairment in Neuromyelitis Optica Spectrum Disorder With Visual Network Reorganization
33. Anatomical Wiring and Functional Networking Changes in the Visual System Following Optic Neuritis
34. High risk of postpartum relapses in neuromyelitis optica spectrum disorder
35. Fatigue as a symptom or comorbidity of neurological diseases
36. Evaluation of Cognitive Deficits and Structural Hippocampal Damage in Encephalitis With Leucine-Rich, Glioma-Inactivated 1 Antibodies
37. Neuromyelitis Optica: Evaluation of 871 Attacks and 1,153 Treatment Courses
38. Low 25-hydroxyvitamin D, but not the bioavailable fraction of 25-hydroxyvitamin D, is a risk factor for multiple sclerosis
39. Assessing Mitochondrial Movement Within Neurons: Manual Versus Automated Tracking Methods
40. Use of Advanced Magnetic Resonance Imaging Techniques in Neuromyelitis Optica Spectrum Disorder
41. Metabolic response to epigallocatechin-3-gallate in relapsing-remitting multiple sclerosis: a randomized clinical trial1–5
42. Oxidative damage to mitochondria at the nodes of Ranvier precedes axon degeneration in ex vivo transected axons
43. The activity of catechol-O-methyltransferase (COMT) is not impaired by high doses of epigallocatechin-3-gallate (EGCG) in vivo
44. Reply to: Photoreceptor layer thinning in Parkinsonian syndromes
45. Photoreceptor layer thinning in idiopathic Parkinsonʼs disease
46. The investigation of acute optic neuritis: a review and proposed protocol
47. Evidence-based patient information programme in early multiple sclerosis: a randomised controlled trial
48. Functional and structural brain changes in anti–N-methyl-D-aspartate receptor encephalitis
49. Characteristics of Susac syndrome: a review of all reported cases
50. What Went Wrong? the Flawed Concept of Cerebrospinal Venous Insufficiency
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.